N-acetylgalactosamine

Europe PMC · from cache · sorted by publication date

1. 1
   Lysosome-directed targeted protein degradation technologies for overcoming cancer drug resistance: mechanisms, design principles, and therapeutic opportunities.

   Mao H, Zhang Y, Liu M, Yao Y, Peng Y, Zhou X, Huang H, Fei W, Zheng C, Ye Y. · 2026-05-27

   open access unreviewed
2. 2
   The mouse gastric surface epithelial cell and its response to early <i>Helicobacter pylori</i> infection.

   Erhardsson M, Santos L, Benktander J, Sharba S, Thorell K, Lindén S. · 2026-03-25

   open access unreviewed
3. 3
   Unlocking the "undruggable": current landscape and emerging frontiers in lysosomal receptor-mediated protein degradation.

   Ma YM, Xia HF, Xiao YL, Yu ZL. · 2026-02-25

   cited 2× open access unreviewed
4. 4
   XFM and HERFD-XAS studies of selenium in tissues and whole blood from mice supplemented with potentially therapeutic selenocompounds.

   Baker AT, Ortiz-Cerda T, Xie K, Hunter J, Dragutinovic I, Morris JC, Vogt LI, George GN, Sokaras D, Howard DL… · 2026-02-16

   cited 1× open access unreviewed
5. 5
   A novel exopolysaccharide from <i>Lactiplantibacillus plantarum</i> H6 improves cholesterol metabolism via <i>Muribaculum-</i>mediated activation of the enterohepatic FXR-FGF15 axis.

   Li Y, Wang J, Wang H, Ma X, Ren D, Wang B. · 2026-02-02

   cited 1× open access unreviewed
6. 6
   Non-Viral CRISPR carriers: transient delivery with lasting effects.

   Lummerstorfer M, Lächelt U. · 2026-01-15

   open access unreviewed
7. 7
   Comparative insights into the gut-heart axis: cross-species and cross-population perspectives.

   Tang TWH, Ullah K, Lee JJ, Chen HC, Hsieh PCH. · 2026-01-11

   cited 2× open access unreviewed
8. 8
   <i><b>Akkermansia muciniphila</b></i> <b>modulates intestinal mucus composition to counteract high-fat diet-induced obesity in mice</b>.

   Paone P, Petitfils C, Puel A, Latousakis D, de Vos WM, Delzenne NM, Juge N, Van Hul M, Cani PD. · 2026-01-09

   cited 2× open access unreviewed
9. 9
   The <i>Pseudomonas aeruginosa sirB2</i> gene is a fitness determinant of anaerobic growth and its inactivation affects virulence and rugose small colony variants emergence.

   Baldelli V, Carrasco Aliaga SJ, Colque CA, Mazzola F, Ravishankar S, Johansen HK, Molin S, Raffaelli N, Paron… · 2025-12-21

   cited 2× open access unreviewed
10. 10
    Structure-coevolution dual-guided engineering of C-glycosyltransferase enables high-level biosynthesis of vitexin in <i>Yarrowia lipolytica</i>.

    Shi CQ, Chen YJ, Yang WL, Zheng S, Cai R, Hou J, Wang DQ, Sheng JZ. · 2026-03-09

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.